Jul 3, 2024 · Apnimed envisions a new era for obstructive sleep apnea (OSA) and other sleep-related breathing diseases—where novel oral therapies simplify treatment and help more …

Jul 3, 2024 · Apnimed is a pharmaceutical company dedicated to breathing new life into the sleep-related breathing disease treatment landscape through innovation in oxygenation. Deep …

Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders.

Oct 31, 2023 · Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, Mass., the …

See real-time Apnimed price charts, funding & market data. Connect with the world's best Apnimed brokers to learn how to buy Apnimed stock.

Apr 7, 2025 · Apnimed is a privately held clinical-stage pharmaceutical company dedicated to transforming the treatment landscape for sleep-related breathing diseases. We believe the …

Oct 23, 2024 · Apnimed, Inc., a pharmaceutical company focused on discovery, development, and commercialization of first-in-class oral therapies that address the neuromuscular …

Nov 2, 2023 · As we share a strong commitment to meet unmet needs in sleep disorders such as OSA, and highly complementary capabilities, we have agreed to establish a joint venture with …

Jul 3, 2024 · Apnimed is a Cambridge, MA-based clinical stage company dedicated to the discovery of novel therapies for sleep apnea and related disorders. The characterization of the …

Apr 7, 2025 · Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea …